Polianta Ltd’s NEVRO CORP. NVRO Stock Holding History

Polianta Ltd’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,600	Closed	-$1.03M	–	105
2020 Q2	$1.03M	Buy	+8,600	New	+$1.02M	0.67%	27

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polianta Ltd's NVRO Position: Q3 2020 in Review

Polianta Ltd sold out of NEVRO CORP. (NVRO) in Q3 2020, closing a stake of 8,600 shares — an estimated $1.03M sold.

Polianta Ltd first reported a position in NVRO in Q2 2020 and held it in 1 quarter. The position peaked at $1.03M in Q2 2020. 210 funds tracked by Wall St. Rank hold NVRO as of Q3 2020.

Polianta Ltd reported no remaining NEVRO CORP. position as of Q3 2020 after selling out during the quarter.
Polianta Ltd sold 8,600 NEVRO CORP. shares in Q3 2020, an estimated $1.03M.
Polianta Ltd first reported a position in NEVRO CORP. in Q2 2020 and held it in 1 quarter.
Polianta Ltd's NEVRO CORP. position peaked at $1.03M in Q2 2020.
210 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2020.

Based on Polianta Ltd's 13F filing for Q3 2020, filed 7 Oct 2020.